Skip to main content
. 2011 Mar 21;34(4):938–943. doi: 10.2337/dc10-1504

Table 3.

Odds ratios and 95% CIs for poor control (HbA1c ≥8) in veterans with type 2 diabetes

Model 1* Model 2* Final model*
Racial/ethnic group (reference: NHW)



    NHB
1.707 (1.683–1.732)
1.353 (1.333–1.374)
1.333 (1.311–1.354)
    Hispanic
1.629 (1.595–1.664)
1.534 (1.499–1.569)
1.572 (1.536–1.608)
    Other
1.905 (1.874–1.937)
1.135 (1.114–1.155)
1.245 (1.222–1.268)
Residence (rural vs. urban)

1.026 (1.014–1.037)
1.020 (1.009–1.032)
Geographic region (reference: Northeast)


    South

0.952 (0.934–0.969)
0.907 (0.890–0.924)
    Mid-Atlantic

1.053 (1.033–1.074)
1.007 (0.987–1.027)
    Midwest

0.941 (0.922–0.959)
0.870 (0.852–0.888)
    West

0.951 (0.931–0.971)
0.894 (0.875–0.913)
Age (1-year increase)

0.959 (0.959–0.960)
0.965 (0.965–0.966)
Sex (female vs. male)

0.920 (0.888–0.953)
0.943 (0.910–0.977)
SCD (1% increase)

0.999 (0.999–1.000)
0.998 (0.998–0.999)
Marital status (single vs. married)

1.149 (1.136–1.161)
1.162 (1.149–1.175)
Medication type used to control diabetes (reference: oral hypoglycemics)

    Insulin


2.349 (2.316–2.383)
    Insulin and oral hypoglycemics


3.530 (3.487–3.573)
Nonadherence (MPR ≤80% vs. >80%)

1.048 (1.038–1.058)
Comorbidities (disease vs. no disease)



    Substance abuse


1.002 (0.975–1.029)
    Anemia


0.837 (0.819–0.856)
    Cancer


0.924 (0.903–0.944)
    Cerebrovascular disease


0.932 (0.915–0.948)
    Congestive heart failure


1.136 (1.116–1.156)
    Cardiovascular disease


1.065 (1.034–1.096)
    Depression


1.071 (1.054–1.088)
    Hypertension


0.907 (0.896–0.919)
    Liver disease


0.766 (0.742–0.790)
    Lung conditions


0.998 (0.973–1.004)
    Electrolyte disorders


1.022 (0.997–1.048)
    Obesity


0.964 (0.949–0.979)
    Psychoses


0.929 (0.905–0.954)
    Peripheral vascular disease


1.033 (1.016–1.051)
    Other disease 0.847 (0.822–0.872)

SCD, service-connected disability.

*Sequentially built models that each include time and time squared.

†Age centered.